BIOCON LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 306.4 INR | +5.06% |
|
+17.10% | +22.73% |
| 04-18 | India's Biocon developing its own version of Wegovy, clinical trial likely next year | RE |
| 04-18 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
Chart calendar Biocon Limited
53363a5a9dd.ipKTOv_n1AxuvEMShdaku3Y0PVvsb3Y2tF9yJRqT6gM.s8DWYKW_jmUr6ihm9rL91ixyeCOGAUZCxCkzXSrBszvM1PFJntHjRVr5ew~e79a1ae887120b612556042bad47929b
Upcoming events on Biocon Limited
Past events on Biocon Limited
| 21/04/2024 | Investor Meeting - Cantor Fitzgerald & Co. |
| 15/04/2024 | Investor Meeting - Subhkam Ventures |
| 07/04/2024 | Investor Meeting - Balyasny Asset Management |
| 01/04/2024 | Investor Meeting - Svan Investments |
| 24/03/2024 | Investor Meeting - Sophus Capital |
| 19/03/2024 | Investor Meeting - Equirus PMS |
| 25/02/2024 | Investor Meeting - Soleus Capital Management |
| 22/02/2024 | Investor Meeting - HSBC Securities India |
| 20/02/2024 | Investor Meeting - British Columbia Investment Management Corp |
| 13/02/2024 | Investor Meeting - White Oak Capital |
| 13/02/2024 | Investor Meeting - Tata Mutual Fund |
| 12/02/2024 | Investor Meeting |
| 09/02/2024 03:30 | Q3 2024 Earnings Call |
| 08/02/2024 13:38 | Q3 2024 Earnings Release |
| 09/01/2024 | Investor Meeting - Stewart Investors |
| 13/12/2023 | Investor Meeting - Aikya Investment Management Limited |
| 11/12/2023 | Investor Meeting - Morgan Stanley Investment Management Company |
| 04/12/2023 | Investor Meeting - Mirae Asset Global Investments (India) Pvt. Ltd |
| 29/11/2023 | Investor Meeting |
| 26/11/2023 | Investor Meeting - Lion Global Investors Limited |
Past dividends on Biocon Limited
| 06/07/2023 | Annual 1.5 INR |
| 29/06/2022 | Annual 0.5 INR |
| 17/07/2019 | Annual 0.5 INR |
| 18/07/2018 | Annual 1 INR |
| 19/07/2017 | Annual 1 INR |
| 16/03/2016 | Interim Payment 5 INR |
| 08/04/2015 | Interim Payment 5 INR |
| 09/07/2014 | Annual 5 INR |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 55 144 56 188 -1.86% | 63 672 66 540 -4.31% | 71 058 73 410 -3.2% | 81 840 80 217 2.02% | 111 742 109 756 1.81% | 145 005 |
|
EBITDA Million INR | Released Forecast Spread | 13 937 14 073 -0.96% | 16 031 17 924 -10.56% | 16 506 17 553 -5.96% | 19 702 19 165 2.8% | 23 447 24 349 -3.7% | 30 198 |
|
EBIT Million INR | Released Forecast Spread | 9 459 9 399 0.64% | 10 509 13 042 -19.42% | 9 355 10 259 -8.81% | 11 560 11 206 3.16% | 12 316 13 432 -8.31% | 14 711 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 12 149 11 843 2.58% | 11 860 13 415 -11.59% | 10 774 10 749 0.24% | 9 831 10 921 -9.98% | 8 971 9 079 -1.19% | 13 493 |
|
Net income Million INR | Released Forecast Spread | 9 053 8 659 4.55% | 7 482 8 885 -15.79% | 7 405 7 332 1% | 6 484 6 868 -5.6% | 4 627 5 222 -11.39% | 9 492 |
|
EPS INR | Released Forecast Spread | 7,60 7,07 7.47% | 6,30 7,49 -15.87% | 6,19 6,03 2.57% | 5,42 5,57 -2.66% | 3,87 4,10 -5.57% | 7,96 |
| Announcement Date | 25/04/19 | 14/05/20 | 28/04/21 | 28/04/22 | 23/05/23 | - |
Quarterly results
| Fiscal Period | March | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 18 387 20 428 -9.99% | 17 606 19 064 -7.65% | 18 404 18 951 -2.89% | 21 742 20 527 5.92% | 24 088 22 337 7.84% | 21 395 22 964 -6.83% | 23 197 22 925 1.19% | 29 411 27 778 5.88% | 37 739 36 262 4.07% | 34 226 35 094 -2.47% | 36 196 | 36 732 | 38 945 | 37 706 |
|
EBITDA Million INR | Released Forecast Spread | 4 358 4 723 -7.72% | 3 893 4 686 -16.93% | 4 458 4 510 -1.16% | 4 882 5 141 -5.03% | 5 919 5 555 6.56% | 3 994 5 697 -29.9% | 4 707 4 805 -2.05% | 6 443 6 203 3.86% | 9 572 8 651 10.64% | 7 144 8 522 -16.17% | 8 475 | 8 373 | 8 219 | |
|
EBIT Million INR | Released Forecast Spread | 2 515 3 121 -19.41% | 1 945 2 842 -31.55% | 2 443 2 606 -6.24% | 2 825 3 158 -10.54% | 3 797 3 685 3.04% | 1 819 3 454 -47.34% | 2 399 2 930 -18.13% | 3 432 2 496 37.48% | 5 935 4 400 34.88% | 3 564 4 684 -23.92% | 4 572 | 4 553 | 4 102 | 3 351 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 3 661 3 448 6.19% | 1 657 2 584 -35.87% | 2 060 2 517 -18.14% | 2 689 3 187 -15.63% | 3 425 3 207 6.81% | 1 969 3 462 -43.13% | 2 291 2 986 -23.28% | -255 3 209 -107.95% | 4 966 3 539 40.32% | 1 837 2 602 -29.4% | 2 676 | 2 930 | 2 319 | |
|
Net income Million INR | Released Forecast Spread | 2 532 2 072 22.2% | 844 1 886 -55.25% | 1 383 1 736 -20.35% | 1 871 2 068 -9.5% | 2 386 2 070 15.27% | 1 444 2 447 -40.99% | 470 1 834 -74.37% | -418 2 136 -119.57% | 3 132 2 704 15.83% | 1 014 1 970 -48.53% | 1 652 | 1 808 | 2 164 | |
|
EPS INR | Released Forecast Spread | 2,12 1,63 30.06% | 0,71 1,36 -47.79% | 1,16 1,46 -20.55% | 1,56 1,37 13.59% | 1,99 1,99 0.25% | 1,21 1,86 -34.83% | 0,39 1,48 -73.6% | -0,35 1,80 -119.44% | 2,62 1,95 34.36% | 0,85 1,58 -46.2% | 1,46 | 1,62 | 1,15 | |
| Announcement Date | 28/04/21 | 22/07/21 | 21/10/21 | 20/01/22 | 28/04/22 | 27/07/22 | 14/11/22 | 14/02/23 | 23/05/23 | 10/08/23 | - | - | - | - |
More events
Past sector events for Biocon Limited
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BIOCON Stock
- Calendar Biocon Limited
